Masi G, Pfanner C,
Millepiedi S, Berloffa S. Aripiprazole
augmentation in 39 adolescents with medication-resistant
obsessive-compulsive disorder. J Clin
Psychopharmacol. 2010 Dec;30(6):688-93.
Masi G, Perugi G,
Millepiedi S, Mucci M, Pfanner C, Berloffa S, Pari C,
Gagliano A, D'Amico F, Akiskal HS. Pharmacological
response in juvenile bipolar disorder subtypes: A naturalistic
retrospective examination.Psychiatry
Res. 2010 May 15;177(1-2):192-8. Epub
2010 Apr 8.
Masi G, Millepiedi S,
Perugi G, Pfanner C, Berloffa S, Pari C, Mucci M, Akiskal
HS. A naturalistic
exploratory study of the impact of demographic, phenotypic and
comorbid features in pediatric obsessive-compulsive
disorder.Psychopathology.
2010;43(2):69-78. Epub 2010 Jan 9.
Masi G, Cosenza A,
Millepiedi S, Muratori F, Pari C, Salvadori F. Aripiprazole
monotherapy in children and young adolescents with pervasive
developmental disorders: a retrospective study.CNS
Drugs. 2009;23(6):511-21.
Masi G, Millepiedi S, Perugi G, Pfanner C, Berloffa S, Pari
C, Mucci M.
Pharmacotherapy in paediatric obsessive-compulsive disorder: a
naturalistic, retrospective study.
CNS Drugs. 2009;23(3):241-52
Masi G, Milone A,
Manfredi A, Pari C, Paziente A, Millepiedi S. Effectiveness of
lithium in children and adolescents with conduct disorder: a
retrospective naturalistic study.CNS
Drugs. 2009;23(1):59-69.
Masi G, Milone A,
Manfredi A, Pari C, Paziente A, Millepiedi S. Comorbidity of conduct
disorder and bipolar disorder in clinically referred children and
adolescents.J Child Adolesc
Psychopharmacol. 2008 Jun;18(3):271-9
Masi G, Milone A,
Manfredi A, Pari C, Paziente A, Millepiedi S. Conduct disorder in
referred children and adolescents: clinical and therapeutic
issues.Compr Psychiatry.
2008 Mar-Apr;49(2):146-53.
Masi G, Perugi G,
Millepiedi S, Mucci M, Pari C, Pfanner C, Berloffa S, Toni
C. Clinical implications
of DSM-IV subtyping of bipolar disorders in referred children and
adolescents.J Am Acad Child Adolesc
Psychiatry. 2007
Oct;46(10):1299-306.
Masi G, Perugi G, Millepiedi
S, Toni C, Mucci M, Pfanner C, Berloffa S, Pari C, Akiskal
HS. Bipolar co-morbidity
in pediatric obsessive-compulsive disorder: clinical and treatment
implications.J Child Adolesc
Psychopharmacol. 2007 Aug;17(4):475-86.
Masi G, Perugi G, Millepiedi
S, Toni C, Mucci M, Bertini N, Pfanner C, Berloffa S, Pari C,
Akiskal K, Akiskal HS. Clinical and research
implications of panic-bipolar comorbidity in children and
adolescents.Psychiatry Res. 2007 Sep
30;153(1):47-54.
Masi G, Perugi G, Millepiedi
S, Mucci M, Toni C, Bertini N, Pfanner C, Berloffa S, Pari
C. Developmental
differences according to age at onset in juvenile bipolar
disorder.J Child Adolesc
Psychopharmacol. 2006 Dec;16(6):679-85.
Masi G, Perugi G, Toni C, Millepiedi S, Mucci M, Bertini N,
Pfanner C.
Attention-deficit hyperactivity disorder -- bipolar comorbidity in
children and adolescents.
Bipolar Disord. 2006 Aug;8(4):373-81.
Masi G, Pari C, Millepiedi
S. Pharmacological
treatment options for panic disorder in children and
adolescents.Expert Opin
Pharmacother. 2006 Apr;7(5):545-54.
Review.
Masi G, Milone A, Canepa G,
Millepiedi S, Mucci M, Muratori F. Olanzapine treatment
in adolescents with severe conduct disorder.Eur Psychiatry. 2006
Jan;21(1):51-7.